Health in Gabon 1,468 indicators covering health for Gabon. IndicatorLatest Year10-yr change Rank Medical doctors not further defined 1 2020 — 150th Leprosy registered prevalence rate per 1 000 000 population 3.08 2025 down 83.4% 73rd Leprosy - Number of cases registered for treatment 8 2025 down 75.0% 92nd Estimate of current cigarette smoking prevalence 10.7% 2030 down 2.7% 96th Estimate of current cigarette smoking prevalence (%) 10.6% 2030 down 1.9% 95th Leprosy - Number of new leprosy cases among children 0 2025 — 77th New leprosy child case detection rate (less than 15 years of age) per 0 2025 — 77th Constant stillbirth rate 12.94 2030 unchanged 56th ENAP target met stillbirth rate 11.66 2030 down 8.5% 55th Stillbirth rate high-income country 2.8 2030 down 73.1% 1st Stillbirths remain constant projection 938 2030 up 3.9% 99th Stillbirth maintained projection 845 2030 down 5.1% 99th Stillbirth ENAP 2030 target met projection 845 2030 down 5.1% 96th Stillbirth high-income country average rate matched projection 201 2030 down 72.2% 113th Stillbirth rate current trends 11.66 2030 down 8.5% 55th Life satisfaction vs. life expectancy 68.34 years 2023 up 3.9% 183rd Number of female leprosy new cases 2 2025 down 81.8% 92nd Low birth weight prevalence 14.6% 2020 down 3.3% 34th Tuberculosis patients who tested positive for HIV 704 patients 2021 up 21.8% 48th Number of children aged 6-59 months with anaemia 183.18 2019 up 28.1% 98th Prevalence of anaemia in children aged 6-59 months 57.9% 2019 down 9.1% 28th Mean hemoglobin level of children aged 6-59 months 106 2019 up 1.9% 167th Estimated number of MDR/RR-TB incident cases 460 2024 down 45.9% 56th Neonatal mortality rate - Remains constant 16.34 2030 unchanged 56th Neonatal mortality rate - Current trends maintained 13.71 2030 down 13.6% 57th Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 77.0% 1st Neonatal mortality rate - SDG target met 12 2030 down 22.7% 1st Under 5 mortality rate - Remains constant 32.63 2030 unchanged 55th Under 5 mortality rate - Current trends maintained 26.67 2030 down 15.4% 57th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 78.7% 1st Under 5 mortality rate - SDG target met 24.91 2030 down 20.1% 35th Mortality rate age 10-19 - Remains constant 8.5 2030 down 0.2% 47th Mortality rate age 10-19 - Current trends maintained 7.2 2030 down 13.1% 44th Mortality rate age 10-19 - High-income country average rate matched 3.85 2030 down 38.5% 76th Neonatal deaths - Remains constant 1,169 2030 up 3.5% 93rd Neonatal deaths - Current trends maintained 980 2030 down 10.6% 94th Neonatal deaths - SDG target met 858 2030 down 20.0% 93rd Under-five deaths - Remains constant 2,306 2030 up 2.9% 89th Under-five deaths - Current trends maintained 1,886 2030 down 12.9% 90th Under-five deaths - SDG target met 1,761 2030 down 17.7% 88th Deaths age 10 to 19 - Remains constant 519 2030 up 14.6% 106th Deaths age 10 to 19 - Current trends maintained 438 2030 down 0.9% 107th Number of deaths attributed to non-communicable diseases, by type of 1,017 2019 up 28.5% 150th Hepatitis B surface antigen (HBsAg) prevalence 3.2% 2024 up 3.2% 3rd Mortality caused by road traffic injury 23.9 per 100,000 population 2019 down 5.2% 51st Mortality caused by road traffic injury, female 12.1 per 100,000 female population 2019 down 15.4% 55th Mortality caused by road traffic injury, male 35.2 per 100,000 male population 2019 down 1.9% 52nd Number of new G2D leprosy cases 6 2025 down 14.3% 51st Leprosy - New leprosy cases with G2D rate per 1 000 000 population 2.31 2025 down 36.2% 34th Share of one-year-olds who received the inactivated polio vaccine 61.0% 2024 down 17.6% 187th HIV-positive TB patients on ART (antiretroviral therapy) 85.0% 2024 up 7.6% 106th Tuberculosis patients living with HIV receiving antiretroviral therapy 472 patients 2021 up 35.6% 52nd Treatment success rate for patients treated for MDR-TB 54.0% 2022 down 5.3% 136th Treatment success rate: HIV-positive TB cases 36 2011 down 10.0% 144th Estimated number of children (aged 0-17 years) who have lost one or 86,000 2024 up 26.5% 89th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 0.0% 2025 — 167th International Health Regulations core capacity scores, SPAR version 40 2025 — 112th Estimated number of malaria cases 474,789 2024 up 23.8% 39th Children (0-14) living with HIV 2,400 2024 down 35.1% 43rd Number of one-year-olds who have not received the inactivated polio vaccine 24,010 one-year-olds 2023 up 52.5% 71st ← Previous Page 21 of 25 Next →